携带LRRK2-G2019S突变的人类iPSC衍生的微质体显示了与帕金森病相关的转录特征和功能
Sohvi Ohtonen1, Luca Giudice2, Henna Jäntti2,3,4
1A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland. sohvi.ohtonen@uef.fi.
Scientific reports
|December 13, 2023
概括
帕金森病 (PD) 中的LRRK2-G2019S突变会改变人类微状细胞 (iMGLs). 这些LRRK2-G2019S iMGLs显示了PD大脑中的转录与微质细胞的重叠,验证了它们作为PD研究模型的使用.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 细胞生物学 细胞生物学
背景情况:
- LRRK2-G2019S突变是与帕金森病 (PD) 相关的常见遗传因素.
- 微质细胞,大脑的免疫细胞,与PD的发病有关,但它们对LRRK2突变的特定反应尚未完全理解.
- 携带LRRK2-G2019S突变的人类诱导多能干细胞衍生微状细胞 (iMGLs) 的转录特征及其与特异性PD微细胞的相关性在很大程度上是未知的.
研究的目的:
- 研究LRRK2-G2019S突变对人类iMGLs的转录特征的影响.
- 为了比较LRRK2-G2019S iMGLs的转录特征与异常帕金森病 (PD) 大脑中的微质细胞.
- 建立LRRK2-G2019S iMGLs作为研究PD相关微质变化的相关体外模型.
主要方法:
- 产生人类诱导的多能干细胞衍生微状细胞 (iMGLs),携带LRRK2-G2019S突变.
- 对iMGL线粒体呼吸,细胞和细胞因子分泌的分析.
- 转录造型的iMGLs和微质转录组的比较从死后的异常病态PD大脑.
主要成果:
- LRRK2-G2019S iMGLs在线粒体呼吸,细胞和细胞因子分泌中表现出微妙的,依赖于供体的变化.
- 在异常病性PD中脑中的微质细胞的一个子集显示了与LRRK2-G2019S iMGL重叠的转录特征.
- 这项研究成功地回顾了LRRK2-G2019S iMGLs中人类异形性PD中脑微质的转录特征的各个方面.
结论:
- LRRK2-G2019S iMGLs作为一种有价值的体外模型来研究帕金森病的机制.
- 这些发现突显了LRRK2-突变iMGLs和在异常PD大脑中发现的微质细胞之间的转录重叠.
- 这项研究提供了关于一种常见的PD相关突变如何影响人类微质功能和基因表达的见解.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.5K
11:19Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
Published on: August 18, 2022
4.0K
相关概念视频
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
